151 related articles for article (PubMed ID: 8370831)
1. MR detection of degenerating uterine leiomyomas.
Okizuka H; Sugimura K; Takemori M; Obayashi C; Kitao M; Ishida T
J Comput Assist Tomogr; 1993; 17(5):760-6. PubMed ID: 8370831
[TBL] [Abstract][Full Text] [Related]
2. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
Yamashita Y; Torashima M; Takahashi M; Tanaka N; Katabuchi H; Miyazaki K; Ito M; Okamura H
Radiology; 1993 Dec; 189(3):721-5. PubMed ID: 8234695
[TBL] [Abstract][Full Text] [Related]
3. Value of magnetic resonance imaging in predicting efficacy of GnRH analogue treatment for uterine leiomyoma.
Takahashi K; Okada M; Imaoka I; Sugimura K; Miyazaki K
Hum Reprod; 2001 Sep; 16(9):1989-94. PubMed ID: 11527910
[TBL] [Abstract][Full Text] [Related]
4. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
Hricak H; Finck S; Honda G; Göranson H
AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
[TBL] [Abstract][Full Text] [Related]
5. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment.
Murase E; Siegelman ES; Outwater EK; Perez-Jaffe LA; Tureck RW
Radiographics; 1999; 19(5):1179-97. PubMed ID: 10489175
[TBL] [Abstract][Full Text] [Related]
6. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
[TBL] [Abstract][Full Text] [Related]
7. Predicting the effect of gonadotropin-releasing hormone (GnRH) analogue treatment on uterine leiomyomas based on MR imaging.
Matsuno Y; Yamashita Y; Takahashi M; Katabuchi H; Okamura H; Kitano Y; Shimamura T
Acta Radiol; 1999 Nov; 40(6):656-62. PubMed ID: 10598858
[TBL] [Abstract][Full Text] [Related]
8. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics.
Swe TT; Onitsuka H; Kawamoto K; Ueyama T; Tsuruchi N; Masuda K
Radiat Med; 1992; 10(6):235-42. PubMed ID: 1287735
[TBL] [Abstract][Full Text] [Related]
9. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
[TBL] [Abstract][Full Text] [Related]
10. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue.
Oguchi O; Mori A; Kobayashi Y; Horiuchi A; Nikaido T; Fujii S
J Obstet Gynaecol (Tokyo 1995); 1995 Apr; 21(2):107-17. PubMed ID: 8556572
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of thymic epithelial tumors.
Kushihashi T; Fujisawa H; Munechika H
Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
[TBL] [Abstract][Full Text] [Related]
12. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
[TBL] [Abstract][Full Text] [Related]
13. Submucosal uterine leiomyomas: diagnosis of prolapse into the cervix and vagina based on MR imaging.
Panageas E; Kier R; McCauley TR; McCarthy S
AJR Am J Roentgenol; 1992 Sep; 159(3):555-8. PubMed ID: 1503024
[TBL] [Abstract][Full Text] [Related]
14. Semiquantitative assessment of MR imaging in prediction of efficacy of gonadotropin-releasing hormone agonist for volume reduction of uterine leiomyoma: initial experience.
Okuda S; Oshio K; Shinmoto H; Tanimoto A; Asada H; Fujii T; Yoshimura Y; Kuribayashi S
Radiology; 2008 Sep; 248(3):917-24. PubMed ID: 18710984
[TBL] [Abstract][Full Text] [Related]
15. High-signal-intensity rim surrounding uterine leiomyomas on MR images: pathologic correlation.
Mittl RL; Yeh IT; Kressel HY
Radiology; 1991 Jul; 180(1):81-3. PubMed ID: 2052728
[TBL] [Abstract][Full Text] [Related]
16. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response.
Broekmans FJ; Heitbrink MA; Hompes PG; Schoute E; Falke T; Schoemaker J
Magn Reson Imaging; 1996; 14(10):1127-35. PubMed ID: 9065902
[TBL] [Abstract][Full Text] [Related]
17. The value of detection of flow voids between the uterus and the leiomyoma with MRI.
Torashima M; Yamashita Y; Matsuno Y; Takahashi M; Nakahara K; Onitsuka Y; Ohtake H; Tanaka N; Okamura H
J Magn Reson Imaging; 1998; 8(2):427-31. PubMed ID: 9562071
[TBL] [Abstract][Full Text] [Related]
18. Triple-phase dynamic MRI of intratumoral vessel density and hyalinization grade in uterine leiomyomas.
Shimada K; Ohashi I; Kasahara I; Miyasaka N; Shibuya H
AJR Am J Roentgenol; 2004 Apr; 182(4):1043-50. PubMed ID: 15039185
[TBL] [Abstract][Full Text] [Related]
19. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
[TBL] [Abstract][Full Text] [Related]
20. MRI findings of uterine lipoleiomyoma correlated with pathologic findings.
Kitajima K; Kaji Y; Imanaka K; Sugihara R; Sugimura K
AJR Am J Roentgenol; 2007 Aug; 189(2):W100-4. PubMed ID: 17646431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
